GlassScriptPhysician profile
William H Crigler
NPI 1043264765
$16,720.73
in general payments reported to CMS, 2019-2025
63 companies · $2,056 in 2025
The $2,056 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,619 · 2020: $1,928 · 2021: $2,730 · 2022: $2,919 · 2023: $3,408 · 2024: $2,061 · 2025: $2,056.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,430 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,429.96 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,892.50 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $1,432.84 | 2021-2025 | Vraylar, Ubrelvy, Linzess |
| Novo Nordisk INC | $1,341.28 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $1,278.18 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $720.37 | 2019-2025 | Xifaxan, Trulance |
| Amgen INC. | $717.17 | 2019-2025 | Otezla, Repatha, Otezla |
| Astellas Pharma US INC | $629.94 | 2019-2025 | Veozah, Myrbetriq |
| Amarin Pharma, INC. | $608.82 | 2019-2023 | |
| Lilly USA, LLC | $557.78 | 2019-2024 | Mounjaro, Jardiance, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $530.58 | 2022-2025 | |
| Kowa Pharmaceuticals America, INC. | $526.79 | 2019-2024 | Livalo, Seglentis |
| Abbott Laboratories | $524.32 | 2019-2025 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $517.43 | 2019-2023 | Jardiance |
| Novartis Pharmaceuticals Corporation | $464.19 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $388.02 | 2019-2025 | Spravato |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $339.53 | 2022-2025 | Rexulti |
| Azurity Pharmaceuticals, INC. | $313.11 | 2023-2025 | Horizant, Horizant, Alvesco |
| Exact Sciences Corporation | $292.51 | 2023-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $277.48 | 2020-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $241.39 | 2020-2025 | Verquvo, Belsomra, Capvaxive |
| Teva Pharmaceuticals USA, INC. | $233.71 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $215.58 | 2022 | |
| Esperion Therapeutics, INC. | $214.48 | 2020-2024 | Nexletol |
| Sumitomo Pharma America, INC. | $196.28 | 2023-2025 | Gemtesa |
| Arbor Pharmaceuticals, INC. | $189.56 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $169.97 | 2019-2023 | |
| Upsher-Smith Laboratories LLC | $156.55 | 2020-2022 | |
| Eisai INC. | $152.47 | 2020-2021 | |
| Antares Pharma, INC. | $149.59 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Takeda Pharmaceuticals U.S.A., INC. | $147.17 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $135.07 | 2023-2025 | Voquezna |
| Allergan, INC. | $126.81 | 2020-2021 | |
| Xeris Pharmaceuticals, INC. | $123.87 | 2022-2024 | Gvoke Hypopen |
| Biohaven Pharmaceuticals, INC. | $106.04 | 2021 | |
| Lundbeck LLC | $92.78 | 2024-2025 | Rexulti, Vyepti |
| Renalytix Ai, INC. | $80.14 | 2023-2024 | Kidneyintelx Blood Collection Convenience Kit |
| Axsome Therapeutics, INC. | $77.48 | 2025 | Sunosi, Auvelity |
| Dexcom, INC. | $61.79 | 2022-2024 | Dexcom G6 Transmitter |
| Inari Medical, INC. | $44.37 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Acerus Pharmaceuticals Corporation | $41.81 | 2022 | |
| Harmony Biosciences LLC | $33.62 | 2023-2024 | Wakix |
| Ironwood Pharmaceuticals, INC | $26.40 | 2020 | |
| Insulet Corporation | $26.07 | 2021 | |
| Boston Scientific Corporation | $21.98 | 2024 | Wavewriter Alpha Prime 16 |
| Alnylam Pharmaceuticals INC. | $20.98 | 2024 | Onpattro |
| Clarus Therapeutics INC. | $20.26 | 2021 | |
| Sunovion Pharmaceuticals INC. | $19.49 | 2021 | |
| Genentech USA, INC. | $18.98 | 2019 | |
| Paratek Pharmaceuticals, INC. | $18.47 | 2025 | Nuzyra |
| Halozyme INC | $17.35 | 2023 | |
| Bausch Health US, LLC | $16.82 | 2019 | |
| Zyla Life Sciences, INC. | $16.49 | 2020 | |
| Tolmar, INC. | $16.19 | 2025 | Jatenzo |
| Almatica Pharma LLC | $15.88 | 2023 | Gralise, Sertraline Hcl, Loreev Xr |
| Scynexis, INC. | $15.85 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $15.48 | 2022 | |
| Idorsia Pharmaceuticals US INC | $15.17 | 2022 | |
| Abiomed | $14.12 | 2025 | |
| Corcept Therapeutics | $13.78 | 2022 | |
| Edwards Lifesciences Corporation | $13.73 | 2021 | |
| Ibsa Pharma INC. | $11.84 | 2019 | |
| Neos Therapeutics, LP | $11.08 | 2020 | |
| Shire North American Group INC | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Crigler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.